Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting 2022-06-07 14:00
SCG Cell Therapy And A*STAR's IMCB Collaborate To Accelerate Clinical Translation of Immune Cell-based Therapy 2022-06-07 12:23
Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule ATR Inhibitor ATG-018 2022-06-07 11:34
Pharmactive Enters Strategic Partnership with Nutraconnect for APAC 2022-06-07 09:00
iNtRON Completes GLP-TOX Studies of BAL200 2022-06-07 09:00
Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory 2022-06-06 21:00
Senhwa's Pindnarulex in Combination Study with Pfizer's Talazoparib for the Treatment of Prostate Cancer Granted Approval to Initiate from Australian HREC 2022-06-06 21:00
ASTRUM-005: Henlius Released Phase 3 Study Results for the First-line Treatment of Small Cell Lung Cancer of Serplulimab at ASCO 2022 2022-06-06 21:00
CARsgen Therapeutics Presents Updated Data for CT041 Claudin18.2 CAR T-cells in Solid Tumors at ASCO 2022 2022-06-06 20:50
Medison Pharma Announces Multi-Regional Partnership Agreement with argenx to Commercialize Efgartigimod Across Europe and Israel 2022-06-06 19:00
NeuroAiD has shown favourable outcome in patients suffering from spinal cord injuries 2022-06-06 18:07
CPHI China opens for international partnering after China rises in CPHI Index 2022-06-06 16:51
CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer 2022-06-06 13:15
CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer 2022-06-06 12:23
GILEAD SCIENCES APPOINTS DUSTIN HAINES AS NEW LEADER FOR ASIA 5 REGION 2022-06-06 11:00
OriCiro Announces Series B2 Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology 2022-06-06 10:09
Research Updates on KN046 Presented at 2022 ASCO 2022-06-06 09:47
WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes 2022-06-06 08:30
JW Therapeutics Presents Latest Data of Carteyva® at 2022 ASCO Annual Meeting 2022-06-05 18:30
Gracell Biotechnologies Schedules Clinical Update Call After EHA2022 2022-06-03 23:00
1 132 133 134 135 136 412